Table 2.
The number of BMC and the content of EPO, IL-2 in each group mice.
| Group | Number (N) | Dose (mg·kg−1) | BMC (×107/femur) | IL-2 (ng/ml) | EPO (ng/ml) |
|---|---|---|---|---|---|
| Blank group | 9 | – | 1.64 ± 0.14 | 4.39 ± 1.56 | 0.23 ± 0.22 |
| Model group | 9 | – | 1.31 ± 0.19* | 3.20 ± 1.73* | 0.19 ± 0.15 |
| Batyl alcohol group | 9 | 10 | 1.73 ± 0.20△△ | 3.19 ± 0.74 | 0.18 ± 0.04 |
| The high dose of ZQFZ granules group | 9 | 15 | 1.45 ± 0.33 | 3.84 ± 0.58 | 0.18 ± 0.05 |
| The medium dose of ZQFZ granules group | 9 | 10 | 1.73 ± 0.36△△ | 3.52 ± 0.63 | 0.24 ± 0.20 |
| The low dose of ZQFZ granules group | 9 | 5 | 1.58 ± 0.40△ | 4.82 ± 1.25△△ | 0.16 ± 0.06 |
Note: compared with the control group: *P < 0.05, **P < 0.01; compared with the model group, Delta P < 0.05, Delta P < 0.01.